CAML:NYE-Congress Large Cap Growth ETF (USD)

ETF | Others |

Last Closing

USD 32.68

Change

0.00 (0.00)%

Market Cap

USD 0.27B

Volume

0.03M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

The fund is an actively-managed exchange-traded fund ("ETF"). The fund adviser attempts to achieve its investment objective by investing at least 80% of its net assets (plus any borrowings for investment purposes) in equity securities of large-capitalization companies. The fund may invest any portion of the remaining 20% of its net assets from time to time in equity securities of small-capitalization and mid-capitalization companies.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-09 )

ETFs Containing CAML

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -3.74% 21% F 28% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -3.74% 21% F 28% F
Trailing 12 Months  
Capital Gain 8.00% 69% C- 66% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 8.00% 63% D 57% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 4.71% 64% D 50% F
Dividend Return 4.71% 58% F 42% F
Total Return 0.00% 1% F 1% F
Risk Return Profile  
Volatility (Standard Deviation) 9.68% 52% F 80% B-
Risk Adjusted Return 48.66% 53% F 62% D
Market Capitalization 0.27B 75% C 40% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.